V
Vincent Brondani
Researcher at Novartis
Publications - 11
Citations - 1548
Vincent Brondani is an academic researcher from Novartis. The author has contributed to research in topics: RNA interference & Small interfering RNA. The author has an hindex of 9, co-authored 11 publications receiving 1509 citations. Previous affiliations of Vincent Brondani include University of Basel.
Papers
More filters
Journal ArticleDOI
Human Dicer preferentially cleaves dsRNAs at their termini without a requirement for ATP
TL;DR: The purification and properties of a recombinant human Dicer are described and it is suggested that if ATP participates in the Dicer reaction in mammalian cells, it might be involved in product release needed for the multiple turnover of the enzyme.
Journal ArticleDOI
Specific interference with gene expression induced by long, double-stranded RNA in mouse embryonal teratocarcinoma cell lines
TL;DR: The RNAi response can be induced effectively by long dsRNA in nondifferentiated mouse cells grown in culture, and siRNAs recently have been shown to act as potent inducers of RNAi in cultured mammalian cells.
Journal ArticleDOI
A new class of HIV-1 Tat antagonist acting through Tat-TAR inhibition.
François Hamy,Vincent Brondani,Andreas Flörsheimer,Wilhelm Stark,Marcel J. J. Blommers,Thomas Klimkait +5 more
TL;DR: The close relation between structural features of the interaction between TAR and a new type of inhibitory agent, "In-PRiNts" (for inhibitor of protein-ribonucleotide sequences), such as CGP 40336A and those of the Tat-TAR complex was confirmed by RNase A footprinting and by two-dimensional NMR.
Journal ArticleDOI
Discovery of novel, highly potent and selective beta-hairpin mimetic CXCR4 inhibitors with excellent anti-HIV activity and pharmacokinetic profiles
Steven J. Demarco,Heiko Henze,Alexander Lederer,Kerstin Moehle,Reshmi Mukherjee,Barbara Romagnoli,John A. Robinson,Federico Brianza,Frank Gombert,Sergio Lociuro,Christian Ludin,Jan Wim Vrijbloed,Jürg Zumbrunn,Jean-Pierre Obrecht,Daniel Obrecht,Vincent Brondani,François Hamy,Thomas Klimkait +17 more
TL;DR: Novel highly potent CXCR4 inhibitors with good pharmacokinetic properties were designed and optimized starting from the naturally occurring beta-hairpin peptide polyphemusin II, which has the potential to become a therapeutic compound for application in the treatment of HIV infections, cancer, angiogenesis suppression and inhibition of metastasis, inflammation, and in stem cell transplant therapy.
Journal ArticleDOI
Inhibition of HIV-1 multiplication by antisense U7 snRNAs and siRNAs targeting cyclophilin A
Songkai Liu,Maria B. Asparuhova,Vincent Brondani,Ingrid Ziekau,Thomas Klimkait,Daniel Schümperli +5 more
TL;DR: Upon lentiviral vector-mediated transduction, prolonged antisense effects were obtained for both types of antisense RNAs in the human T-cell line CEM-SS, and combining the two approaches may result in a synergistic effect.